Literature DB >> 17445312

Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women.

C González1, J Canals, M Ortiz, L Muñoz, M Torres, A García-Saiz, J Del Amo.   

Abstract

The aim of the study was to estimate the prevalence and risk factors associated with infection by high-risk human papillomavirus (HR-HPV) in cervix and squamous intra-epithelial lesions (SIL) in imprisoned women. This was done by a cross-sectional study of imprisoned women attending the gynaecological clinic in Foncalent prison in Alicante, Spain. The study period was from May 2003 to December 2005. HR-HPV infection was determined through Digene HPV Test, Hybrid Capture II (HC-II). HPV typing was determined by multiplex nested PCR assay combining degenerate E6/E7 consensus primers. Multiple logistic regression modelling was used for the analysis of associations between variables where some were considered possible confounders after checking for interactions. A total of 219 women were studied. HR-HPV prevalence was 27.4% and prevalence of SIL was 13.3%. HIV prevalence was 18%, higher in Spaniards than in migrant women (24.6% vs. 14.3%, P<0.05). In multivariate analyses, risk factors for HPV infection were younger age (P for trend=0.001) and tobacco use (OR 2.62, 95% CI 1.01-6.73). HPV infection (OR 4.8, 95% CI 1.7-13.8) and HIV infection were associated with SIL (OR 4.8, 95% CI 1.6-14.1). The commonest HPV types were HPV16 (29.4%), HPV18 (17.6%), HPV39 (17.6%) and HPV68 (17.6%). The prevalence of both HR-HPV infection and SIL in imprisoned women found in this study is high. Determinants for each of the outcomes studied were different. HPV infection is the most important determinant for SIL. A strong effect of HIV co-infection on the prevalence of SIL has been detected. Our findings reinforce the need to support gynaecological clinics in the prison setting.

Entities:  

Mesh:

Year:  2007        PMID: 17445312      PMCID: PMC2870800          DOI: 10.1017/S0950268807008382

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women.

Authors:  J M Palefsky; H Minkoff; L A Kalish; A Levine; H S Sacks; P Garcia; M Young; S Melnick; P Miotti; R Burk
Journal:  J Natl Cancer Inst       Date:  1999-02-03       Impact factor: 13.506

2.  Higher prevalence of human papillomavirus infection in migrant women from Latin America in Spain.

Authors:  C González; M Ortiz; J Canals; L Muñoz; I Jarrín; M G de la Hera; A García-Saiz; J del Amo
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women.

Authors:  H Minkoff; J Feldman; J DeHovitz; S Landesman; R Burk
Journal:  Am J Obstet Gynecol       Date:  1998-05       Impact factor: 8.661

4.  Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women.

Authors:  L Ahdieh; A Muñoz; D Vlahov; C L Trimble; L A Timpson; K Shah
Journal:  Am J Epidemiol       Date:  2000-06-15       Impact factor: 4.897

5.  [HIV, HPV, and syphilis prevalence in a women's penitentiary in the city of São Paulo, 1997-1998].

Authors:  F Lopes; M R Latorre; A C Campos Pignatari; C M Buchalla
Journal:  Cad Saude Publica       Date:  2001 Nov-Dec       Impact factor: 1.632

6.  Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain.

Authors:  J del Amo; C González; J Losana; P Clavo; L Muñoz; J Ballesteros; A García-Saiz; M J Belza; M Ortiz; B Menéndez; J del Romero; F Bolumar
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

7.  [Trends in mortality in a Spanish prison from 1994-2004].

Authors:  Enrique Jesús Vera Remartinez; Manuel Vicente Planelles Ramos; Julio García Guerrero
Journal:  Rev Esp Salud Publica       Date:  2005 Nov-Dec

8.  Human papillomavirus infection in women infected with the human immunodeficiency virus.

Authors:  X W Sun; L Kuhn; T V Ellerbrock; M A Chiasson; T J Bush; T C Wright
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

9.  Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group.

Authors:  S Cu-Uvin; J W Hogan; D Warren; R S Klein; J Peipert; P Schuman; S Holmberg; J Anderson; E Schoenbaum; D Vlahov; K H Mayer
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

10.  [Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners].

Authors:  S de Sanjosé; I Valls; M Paz Cañadas; B Lloveras; M J Quintana; K V Shah; F X Bosch
Journal:  Med Clin (Barc)       Date:  2000-06-17       Impact factor: 1.725

View more
  11 in total

1.  Cervical Cancer Screening Access, Outcomes, and Prevalence of Dysplasia in Correctional Facilities: A Systematic Review.

Authors:  Erin Christine Brousseau; Susie Ahn; Kristen A Matteson
Journal:  J Womens Health (Larchmt)       Date:  2019-04-02       Impact factor: 2.681

2.  3a edizione Giornate della ricerca scientifica e delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) 25-26 marzo 2022.

Authors: 
Journal:  J Prev Med Hyg       Date:  2022-07-06

Review 3.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

4.  Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study.

Authors:  Fernando Cobo; Angel Concha; Marta Ortiz
Journal:  Open Virol J       Date:  2009-09-04

5.  Incarcerated women's HPV awareness, beliefs, and experiences.

Authors:  Tyson Pankey; Megha Ramaswamy
Journal:  Int J Prison Health       Date:  2015

6.  Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: A case study.

Authors:  Amanda Emerson; Molly Allison; Patricia J Kelly; Megha Ramaswamy
Journal:  Vaccine       Date:  2020-02-08       Impact factor: 3.641

7.  "The Vagina is a Very Tricky Little Thing Down There": Cervical Health Literacy among Incarcerated Women.

Authors:  Megha Ramaswamy; Patricia J Kelly
Journal:  J Health Care Poor Underserved       Date:  2015-11

8.  The association between unintended pregnancy and violence among incarcerated men and women.

Authors:  Patricia J Kelly; Megha Ramaswamy
Journal:  J Community Health Nurs       Date:  2012       Impact factor: 0.974

9.  Determining the prevalence of high-risk human papillomavirus infection using a novel cervical precancer screening approach in incarcerated women at the Nsawam Medium Security Prison, Ghana.

Authors:  Lawrence Kofi Acheampong; Kofi Effah; Joseph Emmanuel Amuah; Ethel Tekpor; Comfort Mawusi Wormenor; Isaac Gedzah; Seyram Kemawor; Ateba Cynthia Kachana; Peace Afi Danso; Nana Owusu Mensah Essel; Mabel Asomaning; Dominic Agyiri; Patrick Kafui Akakpo
Journal:  Ecancermedicalscience       Date:  2021-06-14

Review 10.  Vaccinations in prisons: A shot in the arm for community health.

Authors:  Víctor-Guillermo Sequera; Salomé Valencia; Alberto L García-Basteiro; Andrés Marco; José M Bayas
Journal:  Hum Vaccin Immunother       Date:  2015-07-09       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.